JAK Inhibitors for the Treatment of Alopecia Areata

May 2019

Lijuan Yu

JAK inhibitors alopecia areata hair regrowth clinical trials side effects

TLDR JAK inhibitors show promise in treating moderate to severe alopecia areata.

The document reviewed the progress of using JAK inhibitors for treating alopecia areata. It discussed the mechanisms by which JAK inhibitors work, their effectiveness in clinical trials, and potential side effects. The review highlighted that JAK inhibitors showed promise in promoting hair regrowth in patients with alopecia areata, with several studies demonstrating significant improvements. However, it also noted the need for further research to fully understand the long-term safety and efficacy of these treatments.

View this study on rs.yiigle.com →

Discuss this study in the Community →

Related Community Posts Join

6 / 47 results

community I am a dermatologist with a clinical interest in alopecia. AMA

in Will treatment work for me? 2 years ago

In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

community So we’re just ok with taking a research chemical now?

in Treatment 179 upvotes 3 years ago

The conversation discusses the use of RU58841, a non-FDA approved research chemical for hair loss, with mixed opinions on its safety and effectiveness. Some users are willing to try it as a last resort after other treatments like Minoxidil and Finasteride failed, while others express concerns about potential long-term side effects and lack of official research.

community What else is good. Besides the big 3.

in Chat 34 upvotes 2 months ago

Key treatments for hair preservation include minoxidil, finasteride/dutasteride, and microneedling, with additional options like specific shampoos, oils, biotin, zinc, tretinoin, clascoterone, and low-level laser therapy. Maintaining a healthy lifestyle, reducing stress, and addressing nutrient deficiencies can also support hair health.

community Boys I am just a gonner. What on earth is my scalp even going through. Looks like world war 3. Pyril 3 months. Topical melitonin/progesterone/fin, dut, fin, oral min, laser trash, anus stimulation. Nothing. Donor area is decimated 😂.

in Progress Pictures 83 upvotes 2 years ago

Treating Seborrheic Dermatitis, a fungal scalp condition which can cause hair loss. Treatments discussed include antifungal shampoos, cold showers, exfoliating the scalp, taking Vitamin D, and stimulating the prostate through the anus.

community PP405: The Ultimate Hair Loss Drug for Complete Hair Growth

in Research/Science 198 upvotes 2 days ago

PP405 is a new hair loss treatment in phase 2 trials that may promote hair growth by increasing lactate production and activating hair follicle stem cells. It could potentially replace hormone-disrupting treatments like Minoxidil and finasteride.

community Diffuse hair loss and scalp biopsies

in Research 692 upvotes 4 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

Related Research

13 / 13 results

research Tofacitinib Treatment in Patients With Active COVID-19 Infection

2 citations, September 2021 in “Curēus”

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

research Rapidly Progressive Alopecia Areata Totalis in a COVID-19 Patient, Unresponsive to Tofacitinib

14 citations, February 2021 in “Journal of the European Academy of Dermatology and Venereology”

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

research Experience with Oral Tofacitinib in Severe Alopecia Areata with Different Clinical Responses

11 citations, February 2021 in “Journal of Cosmetic Dermatology”

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

research Efficacy of JAK 1/2 Inhibition in the Treatment of Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus

16 citations, January 2020 in “Annals of the rheumatic diseases”

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

research Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata

55 citations, October 2019 in “Dermatology and therapy”

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

research 2-Deoxy D-Glucose Treatment Does Not Elicit a Hair Growth Response in Alopecia Areata

4 citations, July 2019 in “Experimental Dermatology”

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

research Alopecia Universalis Under Adalimumab Therapy in a Patient with Rheumatoid Arthritis

6 citations, May 2018 in “Zeitschrift für Rheumatologie”

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

research Topical Janus Kinase Inhibitors: A Review of Applications in Dermatology

63 citations, April 2018 in “Journal of the American Academy of Dermatology”

Topical JAK inhibitors may help treat some skin conditions but need more research.

research Treatment of an Alopecia Areata Patient with Tofacitinib Results in Regrowth of Hair and Changes in Serum and Skin Biomarkers

70 citations, April 2016 in “Experimental Dermatology”

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

research Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib

184 citations, February 2015 in “EBioMedicine”

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

research Alopecia Universalis Successfully Treated With Adalimumab

37 citations, October 2014 in “JAMA dermatology”

A woman with severe hair loss was successfully treated with the drug adalimumab.

research Alopecia Areata as Another Immune-Mediated Disease Developed in Patients Treated with Tumor Necrosis Factor-Alpha Blocker Agents

61 citations, June 2010 in “Journal of the European Academy of Dermatology and Venereology”

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

research Alopecia Areata Universalis After Phenobarbital-Induced Anticonvulsant Hypersensitivity Syndrome

7 citations, January 2009 in “Immunological investigations”

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.